| Literature DB >> 16282596 |
Christine Beeton1, K George Chandy.
Abstract
Multiple sclerosis is a chronic inflammatory autoimmune disease of the central nervous system characterized by demyelination and axonal damage that result in disabling neurological deficits. Here the authors explain the rationale for the use of inhibitors of the Kv1.3 K+ channel in immune cells as a therapy for multiple sclerosis and other autoimmune disorders.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16282596 DOI: 10.1177/1073858405278016
Source DB: PubMed Journal: Neuroscientist ISSN: 1073-8584 Impact factor: 7.519